The Role of Proteomics in Early Cancer Detection- A Look at Six Core Benefits

Recent advances in proteomic-based technologies have enabled the identification of potential biomarkers that can be used to better detect cancers and track tumor progression.

As cancer progresses, changes in protein profiles and differences in protein distribution (both in tissues and bodily fluids) can be examined through the quantitative profiling of numerous proteins. That’s where proteomic data can deliver substantial value. By adding proteomic algorithmic signature data, you can increase cancer assay specificity and sensitivity, and improve the probability of earlier detection.

Studies that profile proteomic patterns present new opportunities for the development of novel, highly sensitive diagnostic tools for early cancer detection. Explore the 6 core benefits of incorporating proteomics in early cancer biomarker detection.